BlackRock Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

BlackRock Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$153K	Buy	22,070 +432	+2%	+$2.76K	﹤0.01%	2846
2016 Q3	$110K	Buy	21,638 +1,689	+8%	+$10.1K	﹤0.01%	2981
2016 Q2	$119K	Buy	19,949 +11,921	+148%	+$66.2K	﹤0.01%	2881
2016 Q1	$37K	Hold	8,028	–	–	﹤0.01%	3258
2015 Q4	$36K	Hold	8,028	–	–	﹤0.01%	3319
2015 Q3	$25K	Hold	8,028	–	–	﹤0.01%	3460
2015 Q2	$24K	Sell	8,028 -16,680	-68%	-$46.9K	﹤0.01%	3464
2015 Q1	$73K	Buy	24,708 +2,624	+12%	+$8.59K	﹤0.01%	3156
2014 Q4	$98K	Hold	22,084	–	–	﹤0.01%	3054
2014 Q3	$114K	Sell	22,084 -501	-2%	-$2.67K	﹤0.01%	2932
2014 Q2	$119K	Buy	22,585 +14,557	+181%	+$62.9K	﹤0.01%	2962
2014 Q1	$33K	Hold	8,028	–	–	﹤0.01%	3323
2013 Q4	$23K	Hold	8,028	–	–	﹤0.01%	3366
2013 Q3	$20K	Hold	8,028	–	–	﹤0.01%	3319
2013 Q2	$17K	Buy	+8,028	New	+$17.7K	﹤0.01%	3300

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BlackRock Advisors's ENZ Position: Q4 2016 in Review

BlackRock Advisors increased its Enzo Biochem, Inc. (ENZ) stake by 2% in Q4 2016, buying an estimated $2.76K and bringing the position to 22,070 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

BlackRock Advisors first reported a position in ENZ in Q2 2013 and has held it in 15 quarters since. 109 funds tracked by Wall St. Rank hold ENZ as of Q4 2016.

BlackRock Advisors held 22,070 shares of Enzo Biochem, Inc. worth $153K as of Q4 2016.
BlackRock Advisors bought 432 Enzo Biochem, Inc. shares in Q4 2016, an estimated $2.76K.
Enzo Biochem, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2846 holding.
BlackRock Advisors first reported a position in Enzo Biochem, Inc. in Q2 2013 and has held it in 15 quarters since.
109 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.